dipyridamole has been researched along with Hyperlipidemia, Familial Combined in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Hyperlipidemia, Familial Combined: A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pitkänen, OP | 1 |
| Nuutila, P | 1 |
| Raitakari, OT | 1 |
| Porkka, K | 1 |
| Iida, H | 1 |
| Nuotio, I | 1 |
| Rönnemaa, T | 1 |
| Viikari, J | 1 |
| Taskinen, MR | 1 |
| Ehnholm, C | 1 |
| Knuuti, J | 1 |
1 trial available for dipyridamole and Hyperlipidemia, Familial Combined
| Article | Year |
|---|---|
Coronary flow reserve in young men with familial combined hyperlipidemia.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Body Mass Index; Coronary Circulation; Dipyridamole; Hea | 1999 |